OTCPK:BVNRY (Denmark) Also Trade In: Denmark Germany UK

Bavarian Nordic A/S $ 11.75 0 (0%)

Volume:

Avg Vol (1m):

604

Market Cap $:

2.06 Bil

Enterprise Value $:

1.72 Bil

P/E (TTM):

15.18

P/B:

2.15

5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

View Full Chart

What is PE Ratio (TTM)?

Current and historical daily P/E ratio for BVNRY (Bavarian Nordic A/S) from 2013 to Jan 21 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Bavarian Nordic A/S stock (BVNRY) PE ratio as of Jan 21 2021 is 15.18. More Details

Bavarian Nordic A/S PE Ratio (TTM) Chart

EMBED

Bavarian Nordic A/S PE Ratio (TTM) Historical Data

View and export this data going back to 2013. Start your Free Trial

Total 1249

Bavarian Nordic A/S PE Ratio (TTM) Historical Data
Date	PE Ratio (TTM) Data	Date	PE Ratio (TTM) Data
2021-01-21	16.7	2020-11-17	13.1
2021-01-20	16.7	2020-11-16	13.1
2021-01-19	16.7	2020-11-13	13.8
2021-01-15	16.7	2020-11-12	13.8
2021-01-14	16.1	2020-11-11	13.8
2021-01-13	15.0	2020-11-10	13.8
2021-01-12	15.0	2020-11-09	13.8
2021-01-11	15.0	2020-11-06	13.2
2021-01-08	15.0	2020-11-05	13.2
2021-01-07	15.3	2020-11-04	13.2
2021-01-06	15.3	2020-11-03	13.2
2021-01-05	15.3	2020-11-02	13.2
2021-01-04	15.3	2020-10-30	13.2
2020-12-31	15.3	2020-10-29	13.2
2020-12-30	15.3	2020-10-28	13.2
2020-12-29	15.3	2020-10-27	14.8
2020-12-28	15.3	2020-10-26	14.8
2020-12-25	15.4	2020-10-23	14.8
2020-12-24	15.4	2020-10-22	14.8
2020-12-23	15.4	2020-10-21	14.8
2020-12-22	15.4	2020-10-20	14.8
2020-12-21	16.0	2020-10-19	14.8
2020-12-18	16.0	2020-10-16	14.8
2020-12-17	16.1	2020-10-15	14.8
2020-12-16	16.1	2020-10-14	15.7
2020-12-15	15.0	2020-10-13	15.7
2020-12-14	13.8	2020-10-12	15.7
2020-12-11	13.8	2020-10-09	15.7
2020-12-10	13.8	2020-10-08	15.7
2020-12-09	13.8	2020-10-07	15.7
2020-12-08	13.8	2020-10-06	15.7
2020-12-07	14.1	2020-10-05	15.7
2020-12-04	14.1	2020-10-02	15.7
2020-12-03	14.1	2020-10-01	15.7
2020-12-02	13.1	2020-09-30	15.7
2020-12-01	13.1	2020-09-29	15.7
2020-11-30	13.1	2020-09-28	15.7
2020-11-27	13.1	2020-09-25	21.0
2020-11-26	13.1	2020-09-24	21.0
2020-11-25	13.1	2020-09-23	21.0
2020-11-24	13.1	2020-09-22	21.9
2020-11-23	13.1	2020-09-21	21.9
2020-11-20	13.1	2020-09-18	21.9
2020-11-19	13.1	2020-09-17	21.9
2020-11-18	13.1	2020-09-16	21.9

Bavarian Nordic A/S PE Ratio (TTM) Comparison

Company	Market Cap(Mil)	PE Ratio (TTM)

Business Description

Industry Healthcare » Biotechnology »

Compare OCSE:ZEAL OCSE:ALK B OCSE:ORPHA OCSE:NOVO B ASX:CSL NAS:VRTX NAS:REGN XKRX:207940 NAS:SGEN NAS:MRNA NAS:ALXN XKRX:068270 NAS:INCY HKSE:02269 OCSE:GMAB HKSE:01177 SZSE:300122 NAS:BMRN XBRU:UCB NAS:ALNY

Traded in other countries BAVA.Denmark BV3.Germany 0DPB.UK BVNKF.USA

Address Hejreskovvej 10A, Kvistgaard, DNK, 3490

Bavarian Nordic is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the Netherlands, followed by the United States, Canada, and other geographic markets.

Product

Business

Information

About

Affiliate Program

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Earn affiliate commissions by embedding GuruFocus Charts

GuruFocus Affiliate Program: Earn up to $400 per referral. Detailed

Disclaimers

GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.